Loraz and Obstructive uropathy - a phase IV clinical study of FDA data

Summary:

Obstructive uropathy is reported as a side effect among people who take Loraz (lorazepam), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lipitor, and have Prostate cancer.

The phase IV clinical study analyzes which people have Obstructive uropathy when taking Loraz. It is created by eHealthMe based on reports of 161,700 people who have side effects when taking Loraz from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,681 Loraz users. Check the latest studies of Loraz.

What is Obstructive uropathy?

Obstructive uropathy (a blockage that prevents urine from leaving your kidneys) is found to be associated with 182 drugs and 464 conditions by eHealthMe. Check the latest studies of Obstructive uropathy.

On Jul, 25, 2025

161,700 people reported to have side effects when taking Loraz.
Among them, 35 people (0.02%) have Obstructive uropathy.

Among these 35 people:

How long have people been on Loraz when they have Obstructive uropathy? *

What is the gender of people who have Obstructive uropathy when taking Loraz? *

female: 11.43 %
male: 88.57 %

What is the age of people who have Obstructive uropathy when taking Loraz? *

What are other drugs people take besides Loraz? *

What are other side effects people have besides Obstructive uropathy? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 25 people, 71.43%
Urinary Tract Infection: 25 people, 71.43%
Haematuria (presence of blood in urine): 25 people, 71.43%
Hypotension (abnormally low blood pressure): 22 people, 62.86%
Spinal Osteoarthritis (joint cartilage loss in spine): 22 people, 62.86%
Infection: 21 people, 60.00%
Bone Disorder: 21 people, 60.00%
Pain: 21 people, 60.00%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 20 people, 57.14%
Oedema (fluid collection in tissue): 19 people, 54.29%

What are the existing conditions these people have? *

Prostate Cancer: 15 people, 42.86%
Osteoporosis (bones weak and more likely to break): 11 people, 31.43%
High Blood Cholesterol: 10 people, 28.57%
Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 14.29%
High Blood Pressure: 5 people, 14.29%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 8.57%
Cardiac Failure Congestive: 2 people, 5.71%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 2.86%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 2.86%
Diarrhea: 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and have Obstructive uropathy?

- Check whether Obstructive uropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Loraz:

Loraz (165,681 reports)

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Obstructive uropathy:

Obstructive uropathy (182 drugs)

Browse all the conditions that are associated with Obstructive uropathy:

Obstructive uropathy (464 conditions)

Drugs similar to Loraz and Obstructive uropathy :

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Loraz) and Loraz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.